Abiopharma

SmartVest - Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026

Vivani Medical, Inc. Announces Closing of Common Stock Offering

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Johnson & Johnson - DARZALEX FASPRO®-basedquadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

New Form 3 - Zura Bio Ltd <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001995535-26-000004 <b>Size:</b> 12 KB

Merck Announces Second-Quarter 2026 Dividend

New Form 424B5 - Flora Growth Corp. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001062993-26-000448 <b>Size:</b> 328 KB

New Form SCHEDULE 13D - Zura Bio Ltd <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001104659-26-007047 <b>Size:</b> 19 KB

New Form 3 - BIOCRYST PHARMACEUTICALS INC <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001171843-26-000446 <b>Size:</b> 11 KB

New Form 424B3 - Glucotrack, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001493152-26-003822 <b>Size:</b> 281 KB

New Form 3 - Trulieve Cannabis Corp. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0002107378-26-000001 <b>Size:</b> 19 KB

New Form 424B3 - MSP Recovery, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001193125-26-024556 <b>Size:</b> 331 KB